Ingredion Inc. (INGR) announced plans to acquire Tate & Lyle, a £2.7 billion ($5 billion enterprise value) specialty ingredient firm, to accelerate growth in its Global Texture & Healthful Solutions segment—now accounting for roughly 33% of combined revenue. The deal, expected to close in the second half of 2025, will integrate Tate & Lyle’s texture business into Ingredion’s portfolio, where it represents over half of the combined company’s portfolio. Post-merger, the combined entity is targeting annual revenue of approximately $10 billion and EBITDA of $1.8 billion, with $130 million in annual cost synergies, or 4.8% of Tate & Lyle’s revenue, expected to materialize within two years. The acquisition is projected to be accretive by 15% or more to adjusted earnings per share in the first full year after closing, with leverage expected to fall below 2.5x within 18 months of the deal’s execution.
Ingredion’s CEO, Jim, emphasized the strategic shift toward a higher-growth, higher-margin portfolio. ‘With Tate & Lyle, more than half of the combined company’s portfolio will sit in Texture & Healthful Solutions,’ he stated, highlighting the segment’s 9 consecutive quarters of net sales volume growth and a compound annual growth rate of 4%–6%, driven by 1%–2% organic volume expansion and 2%–4% mix improvements. The company also noted a 40% increase in protein fortification sales in the latest quarter and a $600 million skin and hair care business growing at high single-digit rates with premium margins.
Operational challenges have weighed on Ingredion’s performance. A thermal incident at its Argo plant in April 2023 disrupted germ processing, causing operating income losses in Q2, Q3, Q4 of 2023, and Q1 of 2024. The facility stabilized by mid-June 2023, but the disruption contributed to a $20-per-share stock impact. Margins in the U.S./Canada Food and Industrial Ingredients segment fell to 7.8%–8% in Q1 2024 before recovering to 12% in Q2, historically operating at 17%–18%. Meanwhile, divestments in South Korea and Pakistan generated $250 million and $165 million in proceeds, respectively, while earthquake-related infrastructure investments in Colombia’s Cali facility are expected to cost $10 million–$15 million.
Ingredion’s stock, trading near $100, has declined roughly 22% from its 52-week high of $129, reflecting a broader downturn to a 52-week low of $94. The company’s annual revenue stands at about $7.2 billion, with a market capitalization of $6.6 billion. A 3.24% dividend yield has been maintained for 29 consecutive years, with dividends increased for 11 straight years. Cash flow generation has averaged over $1 billion annually in the prior three years, with $700 million–$800 million projected for 2024. Share buybacks totaling $550 million over the past three years have included over $100 million planned for 2024.
The acquisition aligns with Ingredion’s broader strategy to capitalize on trends such as texture-driven food innovation, where texture is increasingly positioned as the ‘new flavor,’ and a K-shaped economic recovery, catering to both premium and affordable consumer segments. The deal underscores Ingredion’s focus on diversifying its growth mix beyond traditional food ingredients into healthful solutions, while managing operational risks through targeted divestitures and strategic investments.
